NASHVILLE—October 10, 2025— Thyme Care and American Oncology Network (AON) announced today that nine jointly developed research abstracts have been accepted for presentation at the American Society of Clinical Oncology (ASCO) Quality Care Symposium 2025, taking place October 10–11 in Chicago, IL. The studies underscore how the organizations’ complementary expertise—AON’s expansive clinical network and real-world care transformation experience, paired with Thyme Care’s technology and analytics—is shaping the future of data-driven, patient-centered, value-based oncology.
The studies reflect real-world insights gained from implementing the Enhancing Oncology Model (EOM), CMS’s current leading oncology value-based care program, across a multi-state network of oncology practices and Medicare beneficiaries. These analyses were co-developed by AON and Thyme Care, drawing on a shared dataset representing thousands of EOM episodes from AON’s multi-state clinical network. With AON representing nearly a tenth of total EOM episodes nationwide, the work provides a robust lens into broader patterns of care, cost, and outcomes.
“This body of research is a powerful validation of what’s possible when collaborative clinical care and data science come together,” said Dr. Bobby Green, co-founder, president, and chief medical officer at Thyme Care. “Having nine abstracts accepted to ASCO Quality demonstrates the strength of our shared model, the quality of AON and Thyme Care’s real-world care redesign experience, and the depth of our collaboration. Together, we’re building and implementing value-based care models that reduce burden, improve outcomes, and truly reflect what matters to patients.”
This research reflects just one aspect of AON and Thyme Care’s broader collaboration to enable value-based oncology care at scale. By combining AON’s extensive patient population and care delivery expertise with Thyme Care’s technology and analytics platform, the partners are delivering actionable solutions that improve quality, reduce the total cost of care, and enhance the patient experience. Their integrated approach goes beyond retrospective reporting—enabling real-time patient tracking, scenario modeling, and economic forecasting that directly inform decisions at the point of care.
A full list of abstract titles and viewing details is listed below:
As CMS refines the EOM and future alternative payment models, AON and Thyme Care’s collaborative work reveals critical insights into how these models function in practice and where they can be improved. Five abstracts offer data-driven recommendations to reduce operational burden, improve fairness, and align cost predictions with clinical realities.
For many patients—particularly those near the end of life—the burden of cancer care can be as significant as the disease itself. Drawing on AON’s clinical platform capabilities and Thyme Care’s value-based care enablement, these studies explore how more thoughtful treatment approaches can reduce burden and better align with patients’ individual values, goals, and preferences.
Health equity sits at the core of value-based care, yet current methodologies may unintentionally penalize practices serving vulnerable populations. AON and Thyme Care’s joint research identifies specific gaps that could undermine model goals and proposes actionable solutions.
Why it matters: A Vision for the Future of Cancer Care
This body of work is a call to action for the oncology ecosystem. By connecting real-world clinical data from AON’s multi-state network with national policy design and advanced analytics from Thyme Care, the partnership is helping reshape how cancer care is measured, reimbursed, and delivered. Together, the organizations demonstrate how value-based care can build a foundation for more compassionate, efficient, and equitable cancer care.
“At American Oncology Network, we’ve seen firsthand how real-time data and aligned care models can improve patient outcomes and reduce cost,” said Dr. Stephen “Fred” Divers, Chief Medical Officer of AON and co-author on all abstracts. “These studies demonstrate the power of collaboration between a robust clinical network and a data-driven value-based care enabler to lead the next generation of value-based oncology.”
About Thyme Care
Thyme Care is the leading value-based care enabler, collaborating with payers and providers to transform the experience and outcomes for individuals living with cancer. The company partners with health plans, employers and risk-bearing providers to assume accountability for enhanced care quality, improved health outcomes, and reduced total cost of care. Thyme Care's approach combines a technology-enabled Care Team and seamless integration with providers, creating a hybrid collaborative care model that guides and supports the entire patient journey. Thyme Care empowers oncologists nationwide through purpose-built tech, advanced data analytics, and virtual patient engagement, driving better care and outcomes in value-based arrangements. To learn more about how Thyme Care is enabling the shift to value-based care in oncology, visit https://www.thymecare.com/
Contact
Kimberly Dreisinger
Thyme Care Communications